Stay updated on Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.5.3 was added and Revision: v3.5.2 was removed, indicating a new page release. This reflects an update to the page's versioning rather than changes to study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-30T16:49:02.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. The update appears to be a technical patch with no changes to the study information presented on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:35:45.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T15:45:44.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 with no changes to study details or locations.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:50.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new site revision marker 'Revision: v3.4.2' was added and the previous 'Revision: v3.4.1' marker was removed. These are routine site maintenance/versioning updates and do not affect study content or availability; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:38.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Administrative notices were added: a government funding lapse notice with status guidance, and a software revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:23:25.000Z thumbnail image

Stay in the know with updates to Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.